IL6 and diabetes mellitus: This effect was only partially reversed with the administration of antibodies against the pro-inflammatory cytokine IL-17 as well as against the inflammatory mediators RANKL and IL-6, indicating a strong correlation between inflammation, oral bacterial composition, and DM (Figure 1) [5].